DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status

por Flanagan, JM, Kugler, S, Waddell, N, Johnstone, CN, Marsh, A, Henderson, S, Simpson, P, da Silva, L, Khanna, K, Lakhani, S, Boshoff, C, Chenevix-Trench, G
Publicado 2010

ctDNA as a biomarker of progression in oesophageal adenocarcinoma

por Bonazzi, V.F., Aoude, L.G., Brosda, S., Lonie, J.M., Patel, K., Bradford, J.J., Koufariotis, L.T., Wood, S., Smithers, B. Mark, Waddell, N., Barbour, A.P.
Publicado 2022

Identification of a novel disease-associated variant in the BRCA1 3’UTR that introduces a functional miR-103 target site

por Brewster, BL, Rossiello, F, French, JD, Edwards, SL, Wong, EM, Whiley, P, Waddell, N, Chen, X, Bove, B, Spurdle, AB, Radice, P, Godwin, AK, Southey, MC, Brown, MA, Peterlongo, P
Publicado 2012

Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers

por Nones, K, Johnson, J, Newell, F, Patch, A M, Thorne, H, Kazakoff, S H, de Luca, X M, Parsons, M T, Ferguson, K, Reid, L E, McCart Reed, A E, Srihari, S, Lakis, V, Davidson, A L, Mukhopadhyay, P, Holmes, O, Xu, Q, Wood, S, Leonard, C, Beesley, J, Harris, J M, Barnes, D, Degasperi, A, Ragan, M A, Spurdle, A B, Khanna, K K, Lakhani, S R, Pearson, J V, Nik-Zainal, S, Chenevix-Trench, G, Waddell, N, Simpson, P T
Publicado 2019

Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels

por Ramarao-Milne, P., Kondrashova, O., Patch, A.-M., Nones, K., Koufariotis, L.T., Newell, F., Addala, V., Lakis, V., Holmes, O., Leonard, C., Wood, S., Xu, Q., Mukhopadhyay, P., Naeini, M.M., Steinfort, D., Williamson, J.P., Bint, M., Pahoff, C., Nguyen, P.T., Twaddell, S., Arnold, D., Grainge, C., Basirzadeh, F., Fielding, D., Dalley, A.J., Chittoory, H., Simpson, P.T., Aoude, L.G., Bonazzi, V.F., Patel, K., Barbour, A.P., Fennell, D.A., Robinson, B.W., Creaney, J., Hollway, G., Pearson, J.V., Waddell, N.
Publicado 2022